alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › blood-based-biomarkers

blood-based-biomarkers

11 studies tagged blood-based-biomarkers, dated 2015-05-11 to 2025-01-10. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Association and multimodal model of retinal and blood-based biomarkers for detection of preclinical Alzheimer's disease 2025-01-10
  2. The impact of exercise on blood-based biomarkers of Alzheimer's disease in cognitively unimpaired older adults 2024-03-15
  3. A blood-based biomarker workflow for optimal tau-PET referral in memory clinic settings 2024-03-14

Studies

11 studies carry this tag.

Date range

2015 to 2025

Top journals

  • Alzheimer's & dementia : the journal of the Alzheimer's Association 3
  • Alzheimer's research & therapy 1
  • Frontiers in neurology 1
  • GeroScience 1
  • JAR life 1

9 journals in all.

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Association and multimodal model of retinal and blood-based biomarkers for detection of preclinical Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 55 out of 100. Alzheimer's research & therapy 2025-01-10 Biomarkers

    A subgroup cohort of 57 eyes from 32 participants with recent Aβ positron emission tomography (PET) results, comprising 18 preclinical patients (Aβ PET + ve, 32 eyes) and 14 controls (Aβ PET -ve, 25 eyes) with a mean age of 69 vs. 66, p = 0.06, was included for the assessment of a multimodal model to distinguish between the two groups.

  2. The impact of exercise on blood-based biomarkers of Alzheimer's disease in cognitively unimpaired older adults

    ✓ Peer-reviewed alzhub usefulness score 71 out of 100. GeroScience 2024-03-15 Biomarkers

    Physical activity is a promising preventative strategy for Alzheimer's disease: it is associated with lower dementia risk, better cognition, greater brain volume and lower brain beta-amyloid.

  3. A blood-based biomarker workflow for optimal tau-PET referral in memory clinic settings

    ✓ Peer-reviewed alzhub usefulness score 60 out of 100. Nature communications 2024-03-14 Biomarkers

    Blood-based biomarkers for screening may guide tau positrion emissition tomography (PET) scan referrals to optimize prognostic evaluation in Alzheimer's disease.

  4. Association between Modifiable Risk Factors and Levels of Blood-Based Biomarkers of Alzheimer's and Related Dementias in the Look AHEAD Cohort

    ✓ Peer-reviewed alzhub usefulness score 62 out of 100. JAR life 2024-01-05 Biomarkers

    Blood-based biomarkers of AD/ADRD are influenced by common demographic and clinical characteristics.

  5. Blood-based biomarkers for Alzheimer's disease and cognitive function from mid- to late life

    ✓ Peer-reviewed alzhub usefulness score 72 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2023-12-21 Biomarkers

    Our findings suggest that mid-life serum AD biomarkers could be associated with accelerated cognitive decline from mid- to late life in women.

  6. The heritability of blood-based biomarkers related to risk of Alzheimer's disease in a population-based sample of early old-age men

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2023-08-25 Biomarkers

    Except for Aβ42/40, plasma biomarkers are heritable.

  7. Fc N-glycosylation of autoreactive Aβ antibodies as a blood-based biomarker for Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 53 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2023-06-01 Biomarkers

    N-glycosylation has been identified as a critical attribute maintaining the beneficial effects of autoreactive Aβ antibodies.

  8. Associations of Midlife Lifestyle and Health Factors with Long-Term Changes in Blood-Based Biomarkers of Alzheimer's Disease and Neurodegeneration

    ✓ Peer-reviewed alzhub usefulness score 55 out of 100. Journal of Alzheimer's disease : JAD 2023-01-01 Biomarkers

    Various lifestyle and health factors, including education and inflammation, were associated with longitudinal changes of neurodegenerative and AD biomarker levels in midlife.

  9. A blood-based biomarker panel indicates IL-10 and IL-12/23p40 are jointly associated as predictors of β-amyloid load in an AD cohort

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Scientific reports 2017-10-25 Biomarkers

    Alzheimer's Disease (AD) is the most common form of dementia, characterised by extracellular amyloid deposition as plaques and intracellular neurofibrillary tangles of tau protein.

  10. Predicting Alzheimer disease from a blood-based biomarker profile: A 54-month follow-up

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Neurology 2016-08-17 Biomarkers

    These findings suggest that a simple blood-based signature not only provides estimates of NAB but also predicts cognitive decline and disease progression, identifying individuals at risk of progressing toward AD at the prodromal and preclinical stages.

  11. The potential of pathological protein fragmentation in blood-based biomarker development for dementia - with emphasis on Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. Frontiers in neurology 2015-05-11 Biomarkers

    The diagnosis of dementia is challenging and early stages are rarely detected limiting the possibilities for early intervention.

All topic tags with their study counts